Formulation and Charaterization of Clotrimazole Microemulsion for Topical Drug Delivery
Journal: International Journal of Science and Research (IJSR) (Vol.10, No. 9)Publication Date: 2021-09-05
Authors : Vamakshi Thaker; A. K. Singhai; Dilip Kumar Tiwari;
Page : 1558-1565
Keywords : Antifungal drug; topical drug delivery system; clotrimazole microemulsion gel;
Abstract
Clotrimazole is a broad - spectrum antimycotic drug, Candida albicans as well as other fungal infections are typically treated with this drug. ?Clinical clotrimazole seems to be a topical therapy treating tineapedis (athlete's foot), vulvo vaginal candidiasis, and oropharyngeal candidiasis.?That is a synthetic azole antimycotic. It inhibits fungal growth by decreasing the production of ergosterol. Clotrimazole has become a medication of interest for a variety of illnesses, including sickle cell anaemia, malaria, and some cancers, in addition to its antimycotic properties. It's been mixed with other molecules as well, to create clotrimazole compounds with enhanced pharmacological effectiveness, including such metals. Numerous novel pharmaceutical formulations enabling variable releases are also being developed. Clotrimazole is a well - tolerated, little - adverse drug, however certain immunocompromised individuals are developing treatment resistance. Clotrimazole's pharmaceutical chemistry, use, and pharmacology are discussed in this study.
Other Latest Articles
- Climate Change, Global Warming and Sustainable Development Goals: Issues and Challenges in India
- Confucian Virtues: A Tool to Enhance Positive Discipline in Schools
- The Application of Machine Learning Techniques for Public Security: An Intelligent Monitoring System to Identify the Faces of Wanted and Sought - After People by Studying the Facial Features through Neural Network Mechanisms
- A Complicated Case of CSOM with Sigmoid Sinus Thrombosis
- Contamination of Underground Water by Heavy Metals: A Case Study of Boreholes around Sony Sugar Factory, Awendo
Last modified: 2022-02-15 18:43:29